Strategic Partnerships Leverage ongoing and recent distributor partnerships with Medtronic, Nihon Kohden, Panakeia and Philips MDIP to accelerate access in Europe, Japan, the US government sector and emerging markets. Target these networks for co-marketing, bundled solutions, and joint opportunities around nociception monitoring.

Expansion Opportunities capitalize on PMD-200 deployment in critical care and its growing international footprint (Canada, Latin America, Israel, Australia, UAE) to push into additional hospital departments such as perioperative care, post-anesthesia care units and acute care telemetry to broaden usage.

Innovative AI Edge Position NOLedge as a predictive and preventive pain management differentiator to hospitals seeking opioid sparing solutions. Highlight potential for cost savings and improved patient outcomes to win RFPs focused on value-based care and reduced length of stay.

Key Leadership Engage the newly appointed Executive Chairman to unlock strategic introductions, advisory leverage, and potential government or large-scale contract opportunities. Align messaging with board-level priorities and clinical outcomes data.

Procurement Readiness Emphasize compatibility with major monitoring ecosystems via Philips and Mindray integrations and IEC 62304 compliance to reduce procurement risk. Target large health systems and Vizient-backed opportunities that favor interoperable nociception monitoring for standardized adoption.